Secondly, it also inhibits the vascular endothelial growth factor receptor 2 (VEGFR-2), c-Kit and platelet-derived growth factor receptor (PDGFR), thus, inhibiting the angiogenesis and tumor cell proliferation indirectly. Here, KDR is linked to neoplasm.